XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance as of beginning of the period (in shares) at Dec. 31, 2022   162,840,360      
Balance as of beginning of the period at Dec. 31, 2022 $ 2,307,745 $ 163 $ 17,358,645 $ (15,008,287) $ (42,776)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   175,761      
Exercise of stock options 1,481   1,481    
Issuance of common stock upon vesting of restricted stock units (in shares)   3,049,824      
Issuance of common stock upon vesting of restricted stock units 0 $ 3 (3)    
Issuance of stock under employee stock purchase plan (in shares)   592,308      
Issuance of stock under employee stock purchase plan 10,440 $ 1 10,439    
Stock-based compensation 220,989   220,989    
Other comprehensive income (loss), net of tax 5,786       5,786
Net loss (220,368)     (220,368)  
Balance as of end of the period (in shares) at Dec. 31, 2023   166,658,253      
Balance as of end of the period at Dec. 31, 2023 2,326,073 $ 167 17,591,551 (15,228,655) (36,990)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   520,190      
Exercise of stock options 3,566   3,566    
Issuance of common stock upon vesting of restricted stock units (in shares)   5,634,883      
Issuance of common stock upon vesting of restricted stock units 0 $ 6 (6)    
Issuance of stock under employee stock purchase plan (in shares)   591,690      
Issuance of stock under employee stock purchase plan 5,409   5,409    
Stock-based compensation 158,674   158,674    
Other comprehensive income (loss), net of tax (1,398)       (1,398)
Net loss $ (1,001,245)     (1,001,245)  
Balance as of end of the period (in shares) at Dec. 31, 2024 173,405,016 173,405,016      
Balance as of end of the period at Dec. 31, 2024 $ 1,491,079 $ 173 17,759,194 (16,229,900) (38,388)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares) 11,575 11,575      
Exercise of stock options $ 85   85    
Issuance of common stock upon vesting of restricted stock units (in shares)   4,361,100      
Issuance of common stock upon vesting of restricted stock units 0 $ 4 (4)    
Issuance of stock under employee stock purchase plan (in shares)   537,709      
Issuance of stock under employee stock purchase plan 3,241 $ 1 3,240    
Stock-based compensation 87,963   87,963    
Other comprehensive income (loss), net of tax 3,660       3,660
Net loss $ (200,322)     (200,322)  
Balance as of end of the period (in shares) at Dec. 31, 2025 178,315,400 178,315,400      
Balance as of end of the period at Dec. 31, 2025 $ 1,385,706 $ 178 $ 17,850,478 $ (16,430,222) $ (34,728)